Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline
- 1 May 1999
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 52 (5) , 465-477
- https://doi.org/10.1054/mehy.1997.0684
Abstract
No abstract availableKeywords
This publication has 210 references indexed in Scilit:
- A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal womenJournal of Bone and Mineral Research, 1996
- Testosterone and Regional Fat DistributionObesity Research, 1995
- Fibrinogen in Obesity Before and After Weight ReductionObesity Research, 1995
- Decline in the Risk of Myocardial Infarction among Women Who Stop SmokingNew England Journal of Medicine, 1990
- The Effect of Dietary Supplementation with n—3 Polyunsaturated Fatty Acids on the Synthesis of Interleukin-1 and Tumor Necrosis Factor by Mononuclear CellsNew England Journal of Medicine, 1989
- Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofyllineBiochemical and Biophysical Research Communications, 1988
- The Risk of Myocardial Infarction after Quitting Smoking in Men under 55 Years of AgeNew England Journal of Medicine, 1985
- Effect of Dietary Enrichment with Eicosapentaenoic and Docosahexaenoic Acids on in Vitro Neutrophil and Monocyte Leukotriene Generation and Neutrophil FunctionNew England Journal of Medicine, 1985
- Arachidonic acid metabolites regulate interleukin-1 productionBiochemical and Biophysical Research Communications, 1985
- Leukocyte Count, Smoking, and Myocardial InfarctionNew England Journal of Medicine, 1981